Literature DB >> 19430206

Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2.

Francesc X Soriano1, Sofia Papadia, Karen F S Bell, Giles E Hardingham.   

Abstract

Peroxiredoxins are neuroprotective antioxidant enzymes that reduce hydroperoxides and protect neurons against oxidative stress. However, they can be inactivated through hyperoxidation of their active site cysteine, an event that can take place in the brain in response to oxidative insults such as stroke and also normal aging. Synaptic activity promotes the reduction of hyperoxidized peroxiredoxins in neurons, and induces the expression of sulfiredoxin (Srxn1) and sestrin 2 (Sesn2) which have been reported to mediate this. We have investigated the importance of histone acetylation in the regulation of these genes, to understand more about how these genes are regulated by synaptic activity. We show that the sestrin 2 promoter undergoes activity-dependent histone acetylation, which contributes to its transcriptional activation. In contrast, promoter-proximal histone acetylation is not involved in the activity-dependent induction of sulfiredoxin. Nevertheless, expression of both sestrin 2 and sulfiredoxin can be induced by enhancing histone acetylation through treatment of neurons with the histone deacetylase inhibitor trichostatin A (TSA). Furthermore, protective doses of TSA inhibit the formation of hyperoxidized peroxiredoxins in neurons exposed to oxidative insults. Histone deacetylases are emerging therapeutic targets in neurodegenerative disorders associated with oxidative stress. Our results indicate that manipulating the histone acetylase-deacetylase balance in neurons may mimic the effects of synaptic activity in preventing the oxidative inactivation of peroxiredoxins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430206      PMCID: PMC2830533          DOI: 10.4161/epi.4.3.8753

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  55 in total

1.  Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum.

Authors:  Arvind Kumar; Kwang-Ho Choi; William Renthal; Nadia M Tsankova; David E H Theobald; Hoang-Trang Truong; Scott J Russo; Quincey Laplant; Teresa S Sasaki; Kimberly N Whistler; Rachael L Neve; David W Self; Eric J Nestler
Journal:  Neuron       Date:  2005-10-20       Impact factor: 17.173

2.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

Authors:  G E Hardingham; Y Fukunaga; H Bading
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

3.  Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection.

Authors:  Sofia Papadia; Patrick Stevenson; Neil R Hardingham; Hilmar Bading; Giles E Hardingham
Journal:  J Neurosci       Date:  2005-04-27       Impact factor: 6.167

4.  Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.

Authors:  Hoon Ryu; Junghee Lee; Beatrix A Olofsson; Aziza Mwidau; Alpaslan Dedeoglu; Maria Escudero; Erik Flemington; Jane Azizkhan-Clifford; Robert J Ferrante; Rajiv R Ratan; Alpaslan Deodoglu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-14       Impact factor: 11.205

Review 5.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.

Authors:  Aleksey G Kazantsev; Leslie M Thompson
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

6.  Excitotoxic insults lead to peroxiredoxin hyperoxidation.

Authors:  Frédéric Léveillé; Francesc X Soriano; Sofia Papadia; Giles E Hardingham
Journal:  Oxid Med Cell Longev       Date:  2009 Apr-Jun       Impact factor: 6.543

7.  Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo.

Authors:  Fumiyuki Hattori; Norihito Murayama; Takafumi Noshita; Shinzo Oikawa
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

8.  Inhibition of histone deacetylation protects wildtype but not gelsolin-deficient mice from ischemic brain injury.

Authors:  Ferah Yildirim; Karen Gertz; Golo Kronenberg; Christoph Harms; Klaus B Fink; Andreas Meisel; Matthias Endres
Journal:  Exp Neurol       Date:  2007-12-23       Impact factor: 5.330

9.  Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains.

Authors:  M F Sánchez-Font; J Sebastià; C Sanfeliu; R Cristòfol; G Marfany; R Gonzàlez-Duarte
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

10.  Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.

Authors:  Jun Yao; Margaret Taylor; Fleur Davey; Yimin Ren; Jim Aiton; Peter Coote; Fang Fang; John Xi Chen; Shi Du Yan; Frank J Gunn-Moore
Journal:  Mol Cell Neurosci       Date:  2007-04-01       Impact factor: 4.314

View more
  17 in total

Review 1.  Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.

Authors:  Suet-Hui Ow; Pei-Jou Chua; Boon-Huat Bay
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

2.  Knocking down of the KCC2 in rat hippocampal neurons increases intracellular chloride concentration and compromises neuronal survival.

Authors:  Christophe Pellegrino; Olena Gubkina; Michael Schaefer; Hélène Becq; Anastasia Ludwig; Marat Mukhtarov; Ilona Chudotvorova; Severine Corby; Yuriy Salyha; Sergey Salozhin; Piotr Bregestovski; Igor Medina
Journal:  J Physiol       Date:  2011-03-21       Impact factor: 5.182

Review 3.  Synergy of homocysteine, microRNA, and epigenetics: a novel therapeutic approach for stroke.

Authors:  Anuradha Kalani; Pradeep K Kamat; Suresh C Tyagi; Neetu Tyagi
Journal:  Mol Neurobiol       Date:  2013-02-22       Impact factor: 5.590

4.  Epigenetics: an expanding new piece of the stroke puzzle.

Authors:  William J Pearce
Journal:  Transl Stroke Res       Date:  2011-09       Impact factor: 6.829

5.  The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats.

Authors:  Rita S Strakovsky; Xiyuan Zhang; Dan Zhou; Yuan-Xiang Pan
Journal:  J Nutr Biochem       Date:  2013-11-06       Impact factor: 6.048

6.  Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration.

Authors:  C Song; A Kanthasamy; H Jin; V Anantharam; A G Kanthasamy
Journal:  Neurotoxicology       Date:  2011-07-12       Impact factor: 4.294

Review 7.  Emerging role of epigenetics in stroke: part 1: DNA methylation and chromatin modifications.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Arch Neurol       Date:  2010-11

8.  Suppression of the intrinsic apoptosis pathway by synaptic activity.

Authors:  Frédéric Léveillé; Sofia Papadia; Michael Fricker; Karen F S Bell; Francesc X Soriano; Marc-André Martel; Clare Puddifoot; Marlen Habel; David J Wyllie; Chrysanthy Ikonomidou; Aviva M Tolkovsky; Giles E Hardingham
Journal:  J Neurosci       Date:  2010-02-17       Impact factor: 6.167

9.  Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration.

Authors:  C Song; A Kanthasamy; V Anantharam; F Sun; A G Kanthasamy
Journal:  Mol Pharmacol       Date:  2010-01-22       Impact factor: 4.436

Review 10.  Functional Consequences of Calcium-Dependent Synapse-to-Nucleus Communication: Focus on Transcription-Dependent Metabolic Plasticity.

Authors:  Anna M Hagenston; Hilmar Bading; Carlos Bas-Orth
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-04-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.